{"gene":"DMPK","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1995,"finding":"DMPK mRNA transcription from wild-type and mutant (expanded CTG) alleles occurs at equal levels in skeletal muscle and cell lines of heterozygous DM patients, but post-transcriptional processing (splicing/maturation) of the mutant allele transcript is impaired in proportion to repeat size, resulting in reduced processed mRNA from the DM allele.","method":"Quantitative allele-specific RT-PCR on patient tissue samples and cell lines","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative allele-specific RT-PCR across multiple patient tissues, single lab with clear mechanistic distinction between transcription and processing steps","pmids":["7590731"],"is_preprint":false},{"year":1993,"finding":"Expansion of the CTG repeat in the DMPK 3'UTR results in both reduced levels of primary DMPK transcripts and impaired processing of those transcripts, leading to undetectable levels of processed DMPK mRNA from the mutant allele, as shown in somatic cell hybrids carrying either the normal or mutant allele.","method":"Somatic cell hybridization to isolate individual chromosome 19 homologues, followed by RT-PCR amplification of DMPK coding sequences","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isogenic hybrid cell lines separating alleles, RT-PCR; single lab but clean allele-specific experimental design","pmids":["8288237"],"is_preprint":false},{"year":1997,"finding":"DMPK transcripts derived from expanded CTG alleles are retained within the nucleus and absent from the cytoplasm, above a critical threshold of 80–400 CTG repeats; this nuclear retention is specific to DMPK and does not affect mRNA levels of flanking genes SIX5 or DMWD.","method":"Subcellular fractionation of RNA combined with allele-specific analysis of DMPK transcripts in DM cell lines; quantitative RNA analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — subcellular fractionation with allele-specific quantification; clear threshold effect demonstrated; findings replicated by multiple independent groups","pmids":["9207102"],"is_preprint":false},{"year":1999,"finding":"DMPK gene dosage is a critical determinant of cardiac conduction integrity: DMPK-/- mice develop first-, second-, and third-degree atrioventricular (A-V) block, with specific compromise of the A-V node and His-Purkinje regions; DMPK+/- mice develop first-degree heart block similar to human DM1 patients, establishing haploinsufficiency of DMPK as linked to cardiac conduction disease.","method":"In vivo murine electrophysiology in DMPK knockout mice on defined genetic backgrounds","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout/heterozygous mouse model with quantitative electrophysiology; dose-dependent phenotype; peer-reviewed with defined functional readout","pmids":["10021468"],"is_preprint":false},{"year":1999,"finding":"A mutant DMPK 3'UTR containing expanded CTG repeats acts in cis to reduce protein expression from the associated reporter gene, and the expanded CUG repeat-containing mRNA acts in trans to inhibit myogenic differentiation of C2C12 myoblasts; deletion analysis mapped both effects to the (CTG)n expansion itself and/or the 3' end of the DMPK 3'UTR.","method":"Chimeric reporter constructs with human DMPK 3'UTR in C2C12 mouse myoblasts; deletion analysis; Cre-loxP genetic rescue system","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including reporter assays, deletion analysis, and genetic rescue (Cre-loxP); both cis and trans mechanisms demonstrated in a controlled cell model","pmids":["10484765"],"is_preprint":false},{"year":2000,"finding":"DMPK pre-mRNA undergoes alternative splicing producing six major isoforms with distinct C-terminal sequences and tissue-dependent expression: four ~74 kDa full-length isoforms (heart-, skeletal muscle-, brain-specific) and two ~68 kDa C-terminally truncated isoforms (smooth muscle-specific), arising from combinations of cryptic splice sites in exons 8 and 14 and regulated excision of exons 13/14.","method":"Transgenic DMPK-overexpressor mouse model; transfection of all six full-length mouse cDNAs into cells; characterization of mRNA and protein isoform distributions","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic mouse model plus cell transfection of all isoforms; multiple tissues analyzed; isoform-specific protein expression confirmed","pmids":["10699184"],"is_preprint":false},{"year":2000,"finding":"Four RNA splicing factors—hnRNP C, U2AF, PTB (polypyrimidine tract binding protein), and PSF (PTB-associated splicing factor)—bind to two short regions 3' of the CUG repeat in DMPK 3'UTR; the CUG repeat acts as an essential cis element for a splicing event that produces a novel 3' DMPK exon generating an mRNA isoform that lacks the repeats and is not retained in the nucleus in DM cells.","method":"Identification of splicing factors binding to DMPK 3'UTR regions; characterization of novel splice isoform; analysis of nuclear retention of isoforms in DM cells","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-binding protein identification combined with novel isoform characterization and nuclear retention analysis; single lab","pmids":["10911990"],"is_preprint":false},{"year":2000,"finding":"DMPK overexpression in cultured lens epithelial cells leads to apoptotic-like blebbing of the plasma membrane and reorganization of the actin cytoskeleton; enzymatically active DMPK (but not kinase-inactive mutant DMPK) is required for both effects, and active RhoA produces similar effects, suggesting DMPK and RhoA function in the same regulatory network.","method":"Overexpression of wild-type and kinase-inactive DMPK mutants in lens epithelial cells; comparison with constitutively active and GDP-state RhoA mutants; assessment of actin cytoskeletal morphology and membrane blebbing","journal":"Cell motility and the cytoskeleton","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — active-site mutagenesis combined with overexpression and comparison to RhoA pathway; single lab; cellular phenotype with defined kinase-activity requirement","pmids":["10658209"],"is_preprint":false},{"year":2001,"finding":"GFP-tagged MBNL protein co-localizes with expanded DMPK repeat transcript nuclear foci in DM1 cell lines, forming discrete nuclear foci itself only in DM1 (not normal) cells, providing evidence that MBNL is sequestered by expanded CUG repeat DMPK transcripts.","method":"Indirect immunofluorescence and overexpression of GFP-tagged MBNL, CUG-BP, and hnRNP C in DM1 cell lines; co-localization with expanded repeat RNA foci","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-localization by fluorescence imaging; single lab; replicated by multiple groups in the field supporting MBNL sequestration model","pmids":["11433021"],"is_preprint":false},{"year":2001,"finding":"DMPK protein level is reduced by approximately 50% in DM1 fetal muscle cells relative to normal cells; mutant DMPK transcripts are retained in discrete nuclear foci, and DMPK mRNA levels increase sharply during myoblast differentiation.","method":"Immunoblotting with anti-DMPK antibody; fluorescence in situ hybridization for RNA foci in primary human DM1 myoblasts","journal":"Neuromuscular disorders : NMD","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — immunoblot quantification and FISH; single lab; consistent with multiple reports of DMPK haploinsufficiency","pmids":["11595515"],"is_preprint":false},{"year":2002,"finding":"Mutant DMPK 3'UTR transcripts containing (CUG)200 disrupt C2C12 myoblast differentiation by reducing MyoD protein levels below the threshold required to activate the differentiation program; restoring MyoD levels rescues the differentiation defect.","method":"C2C12 cell culture model with mutant DMPK 3'UTR expression constructs; MyoD protein measurement by immunoblot; E-box reporter assays; MyoD rescue experiment","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (protein quantification, reporter assays, rescue experiment); defined molecular mechanism linking mutant DMPK RNA to MyoD reduction and differentiation block","pmids":["12427866"],"is_preprint":false},{"year":2004,"finding":"Transgenic overexpression of human DMPK in mice results in hypertrophic cardiomyopathy (myocardial hypertrophy, myocyte disarray, interstitial fibrosis, calcium overload), myotonic myopathy with sarcolemmal chloride channel deficit, and reduced blood pressure, demonstrating that DMPK overexpression in cardiac, skeletal, and smooth muscle cells causes DM1-like pathological changes.","method":"Aged transgenic mice carrying ~25 extra copies of complete hDMPK gene; cardiac and skeletal muscle histology, electrophysiology (myotonic discharges), blood pressure measurement, exercise testing","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic overexpressor model with multiple orthogonal phenotypic readouts in multiple muscle types; controlled comparison with age-matched wild-type mice","pmids":["15317754"],"is_preprint":false},{"year":2005,"finding":"DMPK splice isoform A localizes predominantly to the outer mitochondrial membrane, while isoform C localizes to the endoplasmic reticulum (in mouse); unique sequence arrangements in C-terminal tail anchors control isoform-specific intracellular membrane targeting; expression of isoforms A/C caused clustering of ER or mitochondria respectively; mutagenesis of basic residues flanking putative transmembrane domains disrupted proper anchoring, identifying DMPK as the first kinase class of tail-anchored proteins.","method":"Expression of individual DMPK isoforms in C2C12 and DMPK-/- myoblast cells; subcellular fractionation; alkaline resistance assay; mutagenesis of tail-anchor basic residues; live-cell imaging of organelle distribution","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — mutagenesis of tail-anchor residues combined with subcellular fractionation, alkaline resistance, and organelle imaging in multiple cell types; multiple orthogonal methods establishing mechanism","pmids":["15684391"],"is_preprint":false},{"year":2007,"finding":"DMPK is a positive modulator of insulin action specifically in muscle: DMPK-deficient mice exhibit impaired insulin signaling in muscle but not in adipocytes or liver (tissues lacking DMPK expression), abnormal glucose tolerance, reduced glucose uptake, and impaired insulin-dependent GLUT4 trafficking in muscle; DMPK mutant analysis showed DMPK is required for correct intracellular trafficking of insulin and IGF-1 receptors.","method":"DMPK knockout mice; glucose tolerance tests; glucose uptake assays; GLUT4 trafficking assays; DMPK mutant constructs in cultured muscle cells; tissue-specific phenotype analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse model with multiple metabolic phenotype readouts; tissue-specific effect correlated with tissue-specific DMPK expression; DMPK mutant analysis in cells; multiple orthogonal methods","pmids":["17987120"],"is_preprint":false},{"year":2013,"finding":"The long DMPK isoforms (DMPK-A/B/C/D) are associated with the outer mitochondrial membrane; DMPK-A kinase activity protects cells from oxidative stress and prevents mitochondrial permeability transition pore (PTP) opening; DMPK forms a multimeric complex with hexokinase II (HK II) and the active form of the tyrosine kinase Src (binding its SH3 domain); DMPK is tyrosine-phosphorylated by Src; both the complex and tyrosine phosphorylation of DMPK increase under oxidative stress; DMPK increases mitochondrial localization of HK II; Src inhibition selectively enhances death in DMPK-expressing cells after HK II detachment.","method":"Co-immunoprecipitation; subcellular fractionation; SH3 domain binding assay; kinase activity assays; DMPK knockdown; oxidative stress treatments; permeability transition pore assay; in vitro myogenesis","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods: co-IP, biochemical fractionation, kinase assay, SH3 binding, PTP assay, functional knockdown; complex membership and phosphorylation directly demonstrated","pmids":["24136222"],"is_preprint":false},{"year":2014,"finding":"The DEAD-box helicase DDX6 interacts with CUG triplet-repeat DMPK mRNA in primary DM1 patient fibroblasts and with CUG-RNA in vitro; DDX6 overexpression reduces nuclear DMPK-mRNA foci and relieves DM1 mis-splicing without changing total CUG-expanded mRNA levels (causes re-localization to cytoplasm); DDX6 knockdown increases nuclear DMPK-mRNA foci and MBNL1 nuclear sequestration; DDX6 unwinds CUG-repeat duplexes in vitro in an ATP-dependent manner.","method":"Co-immunoprecipitation in primary DM1 fibroblasts; in vitro RNA unwinding assay; DDX6 overexpression and knockdown; fluorescence microscopy for RNA foci; splicing assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro helicase assay plus reciprocal cellular experiments (overexpression and knockdown) with multiple readouts (foci, splicing, MBNL1 localization); mechanistic chain from DDX6-CUG binding to foci resolution established","pmids":["24792155"],"is_preprint":false},{"year":2016,"finding":"Dmpk gene deletion or >90% ASO-mediated knockdown of DMPK in cardiac and skeletal muscle of mice does not compromise cardiac function (ECG intervals, ejection fraction) or muscle strength, even under cardiac stress (pressure overload) or muscle stress (myotonia), challenging earlier reports of cardiac defects in DMPK knockout mice.","method":"Dmpk knockout mice on two genetic backgrounds; heterozygous knockout mice treated with DMPK-targeting ASOs; ECG measurement, cardiac ejection fraction, muscle strength testing, pressure overload and myotonia stress models","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout and ASO knockdown on two genetic backgrounds with multiple functional readouts; reports negative/null result for cardiac/muscle function but contradicts an earlier positive report (PMID 10021468); confidence reduced due to contradiction","pmids":["27522499"],"is_preprint":false},{"year":2009,"finding":"Long membrane-anchored DMPK isoforms are the dominant form in heart, diaphragm, and skeletal muscle, while short cytosolic isoforms are highly expressed in bladder and stomach; both isoform types are present in diverse brain regions; DMPK protein is detectable in myoblasts, myotubes, cortical astrocytes, and related cell lines but not in hippocampal neurons.","method":"Immunoblotting and RT-PCR for DMPK isoforms in mouse tissue panels and cultured cell types","journal":"Muscle & nerve","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — protein and mRNA isoform profiling across multiple tissues and cell types; single lab; establishes tissue-specific isoform expression pattern","pmids":["19626675"],"is_preprint":false},{"year":2019,"finding":"Expanded CUG repeats in DMPK 3'UTR RNA form length-dependent hairpin structures with conformational plasticity (including branched structures for long repeats), embedded in an otherwise rigid flanking architecture; SHAPE, DMS, CMCT, and RNase T1 probing showed the flanking sequences maintain fixed structure regardless of repeat length; LNA antisense oligonucleotides designed using this structural model confirmed DMPK knockdown in cells.","method":"SHAPE, DMS, CMCT, and RNase T1 RNA structure probing in vitro; LNA antisense oligonucleotide disruption of base-pairing; functional DMPK knockdown validation in cells","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal in vitro structure probing methods (SHAPE, DMS, CMCT, RNase T1) with functional validation via AON knockdown; rigorous multi-method structural characterization","pmids":["30700578"],"is_preprint":false},{"year":2001,"finding":"CTG repeat expansion in the DMPK gene leads to a loss of a nuclease-hypersensitive chromatin site near the repeat, indicating altered chromatin structure; this chromatin change is associated with markedly reduced DMPK mRNA from expanded alleles, partially reduced SIX5 expression (in congenital DM), but no reduction of DMWD mRNA; most DMPK transcripts from expanded alleles lack exons 13 and 14, suggesting the expansion affects 3' splicing.","method":"PCR-based chromatin sensitivity assay in somatic cell hybrids carrying normal or expanded alleles; semiquantitative multiplex RT-PCR; nested RT-PCR for splice isoform analysis","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — allele-specific analysis in somatic cell hybrids with both chromatin and transcriptional readouts; single lab; multiple methods","pmids":["11592825"],"is_preprint":false},{"year":1995,"finding":"DMPK protein (DMK) in human and rodent tissues is detected as ~74 kDa and ~82 kDa species in cardiac and skeletal muscle; by immunofluorescence, DMK localizes post-synaptically at neuromuscular junctions of skeletal muscle, at intercalated discs of cardiac tissue, and at the apical membrane of ependyma and choroid plexus; synaptic localization was also noted in cerebellum, hippocampus, midbrain and medulla.","method":"Immunoblotting with polyclonal antibody against C-terminal DMPK fusion protein; immunofluorescence microscopy on muscle and brain tissue sections","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — immunofluorescence localization in multiple tissues; specific antibody validated against recombinant DMPK; single lab","pmids":["7655460"],"is_preprint":false},{"year":2000,"finding":"Using a panel of 16 monoclonal antibodies, DMPK was detected as a single ~80 kDa protein exclusively in skeletal muscle, cardiac muscle, and to a lesser extent smooth muscle; a shared epitope at the catalytic site of DMPK was identified using a phage-displayed random peptide library; DMPK shares epitopes with MRCK alpha and beta (related kinases).","method":"Monoclonal antibody panel immunoblotting across human tissue panel; phage-displayed random peptide library for epitope mapping; cDNA library screening","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic monoclonal antibody panel with 16 antibodies; epitope mapping by phage display; single lab but comprehensive tissue survey","pmids":["10958655"],"is_preprint":false}],"current_model":"DMPK encodes a serine/threonine protein kinase (homologous to ROCK/MRCK) expressed predominantly in muscle and heart, existing as multiple alternatively spliced isoforms that differentially localize to the outer mitochondrial membrane or ER via unique C-terminal tail anchors; its kinase activity regulates actin cytoskeletal organization, protects mitochondria from oxidative stress by assembling a HK II–Src complex, and modulates insulin receptor trafficking and muscle insulin action, while haploinsufficiency caused by CTG repeat expansion—which impairs post-transcriptional processing and nuclear export of DMPK mRNA—contributes to cardiac conduction defects and insulin resistance, and the toxic expanded CUG repeat-containing mRNA acts in trans to sequester MBNL proteins, reduce MyoD levels, and disrupt myogenic differentiation."},"narrative":{"mechanistic_narrative":"DMPK encodes a muscle- and heart-enriched serine/threonine protein kinase whose normal cellular role and disease-causing CTG repeat expansion represent two functionally distinct axes [PMID:15317754, PMID:9207102]. As a kinase, DMPK regulates the actin cytoskeleton, with enzymatically active (but not kinase-dead) DMPK driving actin reorganization and membrane blebbing in a manner parallel to active RhoA [PMID:10658209]. Alternative splicing generates multiple isoforms with distinct C-terminal tail anchors that target individual isoforms to either the outer mitochondrial membrane or the endoplasmic reticulum, defining DMPK as a tail-anchored kinase [PMID:10699184, PMID:15684391]. At the mitochondrion, the kinase activity of long DMPK isoforms protects cells from oxidative stress and prevents permeability transition pore opening by assembling a complex with hexokinase II and active Src—which tyrosine-phosphorylates DMPK and stabilizes mitochondrial HK II localization under stress [PMID:24136222]. DMPK also acts as a positive, muscle-specific modulator of insulin action, being required for correct trafficking of insulin/IGF-1 receptors and insulin-dependent GLUT4 trafficking [PMID:17987120]. The DM1 disease mechanism operates through the expanded (CTG)n repeat in the DMPK 3'UTR: above a repeat-length threshold the mutant transcript is poorly processed and retained in the nucleus as discrete RNA foci, halving DMPK protein levels (haploinsufficiency), while flanking-gene transcripts are spared [PMID:8288237, PMID:9207102, PMID:11595515]. The expanded CUG-repeat RNA additionally exerts a trans-dominant toxic gain of function, forming length-dependent hairpin structures [PMID:30700578] that sequester MBNL protein into nuclear foci [PMID:11433021] and reduce MyoD below the level needed to drive myogenic differentiation [PMID:12427866, PMID:10484765]. The RNA helicase DDX6 binds and unwinds CUG-repeat duplexes, relocalizing the toxic transcript to the cytoplasm and relieving mis-splicing [PMID:24792155]. Whether DMPK gene dosage is causally required for cardiac conduction is unresolved within the corpus: an early knockout study reported dose-dependent atrioventricular block [PMID:10021468], whereas a later knockout/ASO study found no cardiac or muscle functional deficit [PMID:27522499].","teleology":[{"year":1993,"claim":"Established that CTG expansion does not simply abolish transcription but instead impairs transcript processing, reframing DM1 as a post-transcriptional rather than purely transcriptional defect.","evidence":"Somatic cell hybrids separating normal and mutant chromosome 19 alleles followed by RT-PCR","pmids":["8288237"],"confidence":"Medium","gaps":["Did not localize where in processing the block occurs","Single-lab allele-specific design"]},{"year":1995,"claim":"Distinguished equal transcription from repeat-length-dependent impaired processing of the mutant allele, quantifying the haploinsufficiency mechanism.","evidence":"Quantitative allele-specific RT-PCR across patient tissues and cell lines","pmids":["7590731"],"confidence":"Medium","gaps":["Mechanism of processing block not defined","No protein-level quantification"]},{"year":1995,"claim":"Defined DMPK protein size and subcellular localization, placing the kinase at neuromuscular junctions, intercalated discs, and synaptic sites.","evidence":"Immunoblotting and immunofluorescence with C-terminal DMPK antibody on muscle and brain tissue","pmids":["7655460"],"confidence":"Medium","gaps":["Antibody could not distinguish isoforms functionally","Localization correlation with function not tested"]},{"year":1997,"claim":"Showed the mutant transcript is retained in the nucleus above a defined repeat threshold and that retention is gene-specific, establishing the physical basis for both haploinsufficiency and RNA toxicity.","evidence":"Subcellular RNA fractionation with allele-specific quantification in DM cell lines","pmids":["9207102"],"confidence":"High","gaps":["Did not identify proteins mediating retention","Did not establish downstream toxicity"]},{"year":1999,"claim":"Demonstrated dose-dependent cardiac conduction disease in DMPK knockout and heterozygous mice, arguing that DMPK haploinsufficiency contributes to DM1 heart block.","evidence":"In vivo electrophysiology in DMPK-/- and DMPK+/- mice","pmids":["10021468"],"confidence":"High","gaps":["Molecular substrate of conduction defect not identified","Later contradicted by negative knockout/ASO study"]},{"year":1999,"claim":"Separated cis (reduced reporter expression) from trans (myogenic differentiation block) effects of the expanded repeat, establishing the dual-mechanism framework for DM1.","evidence":"Chimeric reporter constructs and deletion analysis with Cre-loxP rescue in C2C12 myoblasts","pmids":["10484765"],"confidence":"High","gaps":["Did not identify trans-acting factors mediating toxicity","Effects mapped to repeat region but not single nucleotide resolution"]},{"year":2000,"claim":"Catalogued six tissue-specific spliced isoforms with distinct C-termini, providing the molecular basis for differential isoform targeting and function.","evidence":"Transgenic DMPK-overexpressor mice and transfection of all six cDNAs","pmids":["10699184"],"confidence":"High","gaps":["Functional differences between isoforms not yet assigned","Localization not yet mapped"]},{"year":2000,"claim":"Identified splicing factors binding 3' of the CUG repeat and a repeat-dependent splice event producing a non-retained, repeat-lacking isoform, hinting at an escape route from nuclear retention.","evidence":"RNA-binding protein identification and novel isoform characterization in DM cells","pmids":["10911990"],"confidence":"Medium","gaps":["Physiological relevance of escape isoform not quantified","Single lab"]},{"year":2000,"claim":"Linked DMPK kinase activity to actin cytoskeletal reorganization and membrane blebbing, placing DMPK in a RhoA-related signaling network.","evidence":"Wild-type versus kinase-inactive DMPK overexpression compared with RhoA mutants in lens epithelial cells","pmids":["10658209"],"confidence":"Medium","gaps":["Direct substrates not identified","Non-muscle cell model"]},{"year":2000,"claim":"Confirmed muscle-restricted DMPK expression and a shared catalytic-site epitope with the related kinases MRCK alpha/beta.","evidence":"16-monoclonal-antibody tissue panel and phage-display epitope mapping","pmids":["10958655"],"confidence":"Medium","gaps":["Functional consequence of MRCK relatedness not tested","Single lab"]},{"year":2001,"claim":"Provided direct imaging evidence that MBNL is sequestered onto expanded-repeat DMPK RNA foci, advancing the trans RNA-toxicity model.","evidence":"GFP-tagged MBNL co-localization with repeat RNA foci in DM1 cells","pmids":["11433021"],"confidence":"Medium","gaps":["Co-localization not quantitatively binding affinity","Functional splicing consequences of sequestration not measured here"]},{"year":2001,"claim":"Quantified ~50% DMPK protein reduction in DM1 muscle cells alongside nuclear RNA foci, directly linking nuclear retention to haploinsufficiency.","evidence":"Immunoblotting and FISH in primary human DM1 myoblasts","pmids":["11595515"],"confidence":"Medium","gaps":["Single lab","Causal contribution of 50% loss to phenotype not isolated"]},{"year":2001,"claim":"Connected CTG expansion to altered local chromatin structure and exon 13/14-deficient transcripts, adding a chromatin-level layer to expression silencing.","evidence":"Chromatin sensitivity assay and RT-PCR in somatic cell hybrids","pmids":["11592825"],"confidence":"Medium","gaps":["Chromatin change mechanism not defined","Relative contribution versus RNA retention unclear"]},{"year":2002,"claim":"Pinpointed MyoD depletion below an activation threshold as the molecular cause of repeat-RNA-induced differentiation failure, with MyoD restoration rescuing the defect.","evidence":"(CUG)200 3'UTR constructs, MyoD immunoblot, E-box reporters, and rescue in C2C12","pmids":["12427866"],"confidence":"High","gaps":["Mechanism linking RNA foci to MyoD reduction not fully defined","Cell-line model only"]},{"year":2004,"claim":"Demonstrated that DMPK overexpression alone reproduces DM1-like cardiac, skeletal, and smooth muscle pathology, implicating dosage in disease beyond loss of function.","evidence":"Transgenic mice with ~25 extra hDMPK copies; histology, electrophysiology, blood pressure","pmids":["15317754"],"confidence":"High","gaps":["Overexpression level non-physiological","Does not separate kinase activity from gene dosage"]},{"year":2005,"claim":"Established isoform-specific tail-anchor targeting to mitochondria versus ER, identifying DMPK as the first tail-anchored protein kinase and giving a structural basis for compartmentalized function.","evidence":"Isoform expression, subcellular fractionation, alkaline resistance, tail-anchor mutagenesis, and imaging in myoblasts","pmids":["15684391"],"confidence":"High","gaps":["Functional output at each organelle not yet defined","Targeting machinery not identified"]},{"year":2007,"claim":"Defined DMPK as a muscle-specific positive regulator of insulin signaling required for insulin/IGF-1 receptor and GLUT4 trafficking, linking DMPK loss to the insulin resistance of DM1.","evidence":"Knockout mice with glucose tolerance, uptake, and GLUT4 trafficking assays plus DMPK mutant cells","pmids":["17987120"],"confidence":"High","gaps":["Direct kinase substrates in the trafficking pathway not identified","Molecular link between DMPK and receptor trafficking unresolved"]},{"year":2009,"claim":"Refined the tissue map of membrane-anchored versus cytosolic DMPK isoforms across muscle, visceral, and brain tissues, framing where each functional pool acts.","evidence":"Immunoblot and RT-PCR isoform profiling across mouse tissues and cell types","pmids":["19626675"],"confidence":"Medium","gaps":["Functional consequence of isoform distribution not tested","Single lab"]},{"year":2013,"claim":"Resolved a mitochondrial protective mechanism in which long DMPK isoforms assemble an HK II–Src complex, are tyrosine-phosphorylated by Src, and prevent permeability transition pore opening under oxidative stress.","evidence":"Co-IP, fractionation, SH3 binding, kinase and PTP assays, and knockdown under oxidative stress","pmids":["24136222"],"confidence":"High","gaps":["Direct DMPK phosphorylation substrates at the mitochondrion not identified","In vivo relevance to DM1 not established"]},{"year":2014,"claim":"Identified DDX6 as a CUG-repeat helicase that unwinds the toxic duplex, relocalizes the transcript to the cytoplasm, and relieves MBNL1 sequestration and mis-splicing, offering a route to counter RNA toxicity.","evidence":"Co-IP in DM1 fibroblasts, in vitro ATP-dependent unwinding, and reciprocal overexpression/knockdown","pmids":["24792155"],"confidence":"High","gaps":["Endogenous regulation of DDX6 in DM1 tissue not addressed","Therapeutic feasibility untested"]},{"year":2019,"claim":"Provided a structural model of length-dependent CUG hairpins within a rigid flanking architecture and validated structure-guided antisense knockdown.","evidence":"SHAPE/DMS/CMCT/RNase T1 probing in vitro plus LNA antisense knockdown in cells","pmids":["30700578"],"confidence":"High","gaps":["Structure of repeat in cellular context with bound proteins not resolved","Branched-structure functional consequence not defined"]},{"year":null,"claim":"Whether DMPK gene dosage is causally required for cardiac conduction and muscle function in vivo remains unresolved, given directly contradictory knockout results.","evidence":"Contradiction between dose-dependent AV block (10021468) and null cardiac/muscle phenotype under stress (27522499)","pmids":[],"confidence":"Medium","gaps":["Genetic background and modifier effects not reconciled","Direct kinase substrates underlying any cardiac role not identified","Relative weighting of haploinsufficiency versus RNA toxicity in cardiac disease unsettled"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[7,14]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[7,14,21]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[12,14,17]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[12]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[20]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,9]}],"pathway":[{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,4,10]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[6,8,15]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,10]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,13]}],"complexes":["DMPK–hexokinase II–Src mitochondrial complex"],"partners":["HK2","SRC","MBNL1","DDX6"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q09013","full_name":"Myotonin-protein kinase","aliases":["DM-kinase","DMK","DM1 protein kinase","DMPK","Myotonic dystrophy protein kinase"],"length_aa":629,"mass_kda":69.4,"function":"Non-receptor serine/threonine protein kinase which is necessary for the maintenance of skeletal muscle structure and function. May play a role in myocyte differentiation and survival by regulating the integrity of the nuclear envelope and the expression of muscle-specific genes. May also phosphorylate PPP1R12A and inhibit the myosin phosphatase activity to regulate myosin phosphorylation. Also critical to the modulation of cardiac contractility and to the maintenance of proper cardiac conduction activity probably through the regulation of cellular calcium homeostasis. Phosphorylates PLN, a regulator of calcium pumps and may regulate sarcoplasmic reticulum calcium uptake in myocytes. May also phosphorylate FXYD1/PLM which is able to induce chloride currents. May also play a role in synaptic plasticity","subcellular_location":"Mitochondrion membrane","url":"https://www.uniprot.org/uniprotkb/Q09013/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DMPK","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DMPK","total_profiled":1310},"omim":[{"mim_id":"613385","title":"AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD","url":"https://www.omim.org/entry/613385"},{"mim_id":"609857","title":"DYSTROPHIA MYOTONICA WD REPEAT-CONTAINING PROTEIN; DMWD","url":"https://www.omim.org/entry/609857"},{"mim_id":"609117","title":"F-BOX ONLY PROTEIN 46; FBXO46","url":"https://www.omim.org/entry/609117"},{"mim_id":"608768","title":"SPINOCEREBELLAR ATAXIA 8; SCA8","url":"https://www.omim.org/entry/608768"},{"mim_id":"607327","title":"MUSCLEBLIND-LIKE SPLICING REGULATOR 2; MBNL2","url":"https://www.omim.org/entry/607327"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Cytosol","reliability":"Uncertain"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"heart muscle","ntpm":145.9},{"tissue":"skeletal muscle","ntpm":193.1},{"tissue":"tongue","ntpm":138.8}],"url":"https://www.proteinatlas.org/search/DMPK"},"hgnc":{"alias_symbol":["DMK","DM1PK","MDPK","MT-PK"],"prev_symbol":["DM1","DM"]},"alphafold":{"accession":"Q09013","domains":[{"cath_id":"3.30.200.20","chopping":"66-152_360-386_400-414","consensus_level":"medium","plddt":88.3911,"start":66,"end":414},{"cath_id":"1.10.510.10","chopping":"155-357","consensus_level":"medium","plddt":93.1707,"start":155,"end":357},{"cath_id":"1.20.5","chopping":"2-63","consensus_level":"high","plddt":90.6442,"start":2,"end":63}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q09013","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q09013-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q09013-F1-predicted_aligned_error_v6.png","plddt_mean":77.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DMPK","jax_strain_url":"https://www.jax.org/strain/search?query=DMPK"},"sequence":{"accession":"Q09013","fasta_url":"https://rest.uniprot.org/uniprotkb/Q09013.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q09013/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q09013"}},"corpus_meta":[{"pmid":"18268317","id":"PMC_18268317","title":"A W-linked DM-domain gene, DM-W, participates in primary ovary development in Xenopus laevis.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18268317","citation_count":369,"is_preprint":false},{"pmid":"22310892","id":"PMC_22310892","title":"Sex and the singular DM domain: insights into sexual regulation, evolution and plasticity.","date":"2012","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22310892","citation_count":296,"is_preprint":false},{"pmid":"15376325","id":"PMC_15376325","title":"Two DM domain genes, DMY and DMRT1, involved in testicular differentiation and development in the medaka, Oryzias latipes.","date":"2004","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15376325","citation_count":235,"is_preprint":false},{"pmid":"1873027","id":"PMC_1873027","title":"DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension.","date":"1991","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/1873027","citation_count":202,"is_preprint":false},{"pmid":"11433021","id":"PMC_11433021","title":"In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts.","date":"2001","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11433021","citation_count":179,"is_preprint":false},{"pmid":"20007774","id":"PMC_20007774","title":"The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20007774","citation_count":156,"is_preprint":false},{"pmid":"8358430","id":"PMC_8358430","title":"Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene.","date":"1993","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8358430","citation_count":147,"is_preprint":false},{"pmid":"10021468","id":"PMC_10021468","title":"DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.","date":"1999","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10021468","citation_count":136,"is_preprint":false},{"pmid":"8499920","id":"PMC_8499920","title":"Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene.","date":"1993","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8499920","citation_count":128,"is_preprint":false},{"pmid":"7590731","id":"PMC_7590731","title":"Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7590731","citation_count":122,"is_preprint":false},{"pmid":"32298797","id":"PMC_32298797","title":"Fundamental aspects of DMPK optimization of targeted protein degraders.","date":"2020","source":"Drug discovery today","url":"https://pubmed.ncbi.nlm.nih.gov/32298797","citation_count":121,"is_preprint":false},{"pmid":"8288237","id":"PMC_8288237","title":"Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8288237","citation_count":118,"is_preprint":false},{"pmid":"9207102","id":"PMC_9207102","title":"Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9207102","citation_count":117,"is_preprint":false},{"pmid":"10484765","id":"PMC_10484765","title":"Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10484765","citation_count":114,"is_preprint":false},{"pmid":"24463216","id":"PMC_24463216","title":"HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.","date":"2013","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24463216","citation_count":103,"is_preprint":false},{"pmid":"15008421","id":"PMC_15008421","title":"Evolutionary dynamics of the DM domain gene family in metazoans.","date":"2003","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/15008421","citation_count":101,"is_preprint":false},{"pmid":"26330536","id":"PMC_26330536","title":"Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1.","date":"2015","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/26330536","citation_count":98,"is_preprint":false},{"pmid":"11070170","id":"PMC_11070170","title":"Determination of the HLA-DM interaction site on HLA-DR molecules.","date":"2000","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11070170","citation_count":93,"is_preprint":false},{"pmid":"7495736","id":"PMC_7495736","title":"The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes.","date":"1995","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7495736","citation_count":91,"is_preprint":false},{"pmid":"15722335","id":"PMC_15722335","title":"Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15722335","citation_count":88,"is_preprint":false},{"pmid":"8920863","id":"PMC_8920863","title":"Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.","date":"1996","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8920863","citation_count":88,"is_preprint":false},{"pmid":"16181342","id":"PMC_16181342","title":"The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes.","date":"2005","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/16181342","citation_count":87,"is_preprint":false},{"pmid":"17605809","id":"PMC_17605809","title":"Vertebrate DM domain proteins bind similar DNA sequences and can heterodimerize on DNA.","date":"2007","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17605809","citation_count":79,"is_preprint":false},{"pmid":"16987935","id":"PMC_16987935","title":"Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.","date":"2006","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16987935","citation_count":75,"is_preprint":false},{"pmid":"11595515","id":"PMC_11595515","title":"Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.","date":"2001","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/11595515","citation_count":74,"is_preprint":false},{"pmid":"9949207","id":"PMC_9949207","title":"Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9949207","citation_count":63,"is_preprint":false},{"pmid":"7655460","id":"PMC_7655460","title":"Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue.","date":"1995","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7655460","citation_count":58,"is_preprint":false},{"pmid":"11790529","id":"PMC_11790529","title":"HLA-DM, HLA-DO and tapasin: functional similarities and differences.","date":"2002","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11790529","citation_count":57,"is_preprint":false},{"pmid":"15185171","id":"PMC_15185171","title":"Intergenerational instability of the expanded CTG repeat in the DMPK gene: studies in human gametes and preimplantation embryos.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15185171","citation_count":57,"is_preprint":false},{"pmid":"10699184","id":"PMC_10699184","title":"Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10699184","citation_count":56,"is_preprint":false},{"pmid":"10911990","id":"PMC_10911990","title":"Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.","date":"2000","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10911990","citation_count":56,"is_preprint":false},{"pmid":"18583094","id":"PMC_18583094","title":"Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18583094","citation_count":55,"is_preprint":false},{"pmid":"33025005","id":"PMC_33025005","title":"Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33025005","citation_count":55,"is_preprint":false},{"pmid":"8089660","id":"PMC_8089660","title":"The molecular cloning and characterization of potential chick DM-GRASP homologs in zebrafish and mouse.","date":"1994","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8089660","citation_count":55,"is_preprint":false},{"pmid":"34221871","id":"PMC_34221871","title":"Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment.","date":"2021","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/34221871","citation_count":53,"is_preprint":false},{"pmid":"24136222","id":"PMC_24136222","title":"Myotonic dystrophy protein kinase (DMPK) prevents ROS-induced cell death by assembling a hexokinase II-Src complex on the mitochondrial surface.","date":"2013","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24136222","citation_count":52,"is_preprint":false},{"pmid":"18031985","id":"PMC_18031985","title":"Molecular cloning and sexually dimorphic expression of DM-domain genes in Daphnia magna.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18031985","citation_count":52,"is_preprint":false},{"pmid":"15317754","id":"PMC_15317754","title":"Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15317754","citation_count":51,"is_preprint":false},{"pmid":"12427866","id":"PMC_12427866","title":"Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12427866","citation_count":50,"is_preprint":false},{"pmid":"10993909","id":"PMC_10993909","title":"DM determines the cryptic and immunodominant fate of T cell epitopes.","date":"2000","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10993909","citation_count":49,"is_preprint":false},{"pmid":"16982677","id":"PMC_16982677","title":"Mice mutant in the DM domain gene Dmrt4 are viable and fertile but have polyovular follicles.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16982677","citation_count":48,"is_preprint":false},{"pmid":"31253581","id":"PMC_31253581","title":"Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice.","date":"2019","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31253581","citation_count":47,"is_preprint":false},{"pmid":"27991661","id":"PMC_27991661","title":"Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27991661","citation_count":46,"is_preprint":false},{"pmid":"18854223","id":"PMC_18854223","title":"Identification and expression of a factor of the DM family in the oyster Crassostrea gigas.","date":"2008","source":"Comparative biochemistry and physiology. Part A, Molecular & integrative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18854223","citation_count":46,"is_preprint":false},{"pmid":"19289282","id":"PMC_19289282","title":"Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.","date":"2009","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/19289282","citation_count":46,"is_preprint":false},{"pmid":"10958655","id":"PMC_10958655","title":"Characterization of a monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exclusively in muscle and heart.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10958655","citation_count":45,"is_preprint":false},{"pmid":"26339785","id":"PMC_26339785","title":"Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26339785","citation_count":44,"is_preprint":false},{"pmid":"27522499","id":"PMC_27522499","title":"Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27522499","citation_count":44,"is_preprint":false},{"pmid":"10741860","id":"PMC_10741860","title":"HLA-DM and the MHC class II antigen presentation pathway.","date":"1999","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/10741860","citation_count":44,"is_preprint":false},{"pmid":"22354993","id":"PMC_22354993","title":"Altered replication in human cells promotes DMPK (CTG)(n) · (CAG)(n) repeat instability.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22354993","citation_count":44,"is_preprint":false},{"pmid":"24792155","id":"PMC_24792155","title":"DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24792155","citation_count":42,"is_preprint":false},{"pmid":"18618285","id":"PMC_18618285","title":"Expression of Dm-AMP1 in rice confers resistance to Magnaporthe oryzae and Rhizoctonia solani.","date":"2008","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/18618285","citation_count":41,"is_preprint":false},{"pmid":"16488114","id":"PMC_16488114","title":"Male-biased expression of X-chromosomal DM domain-less Dmrt8 genes in the mouse.","date":"2006","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/16488114","citation_count":41,"is_preprint":false},{"pmid":"36804094","id":"PMC_36804094","title":"Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.","date":"2023","source":"The Lancet. Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36804094","citation_count":40,"is_preprint":false},{"pmid":"27876818","id":"PMC_27876818","title":"Identification and characterization of 5' CCG interruptions in complex DMPK expanded alleles.","date":"2016","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/27876818","citation_count":40,"is_preprint":false},{"pmid":"16174285","id":"PMC_16174285","title":"Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation.","date":"2005","source":"Nephrology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/16174285","citation_count":38,"is_preprint":false},{"pmid":"10704504","id":"PMC_10704504","title":"DM-GRASP is necessary for nonradial cell migration during chick diencephalic development.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10704504","citation_count":38,"is_preprint":false},{"pmid":"12369896","id":"PMC_12369896","title":"The influence of DMPK as an integrated partner in modern drug discovery.","date":"2002","source":"Current drug metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12369896","citation_count":35,"is_preprint":false},{"pmid":"17987120","id":"PMC_17987120","title":"Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17987120","citation_count":33,"is_preprint":false},{"pmid":"19339816","id":"PMC_19339816","title":"Xenopus W-linked DM-W induces Foxl2 and Cyp19 expression during ovary formation.","date":"2009","source":"Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19339816","citation_count":33,"is_preprint":false},{"pmid":"11592825","id":"PMC_11592825","title":"Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.","date":"2001","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11592825","citation_count":33,"is_preprint":false},{"pmid":"10732765","id":"PMC_10732765","title":"Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells.","date":"2000","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10732765","citation_count":32,"is_preprint":false},{"pmid":"12646641","id":"PMC_12646641","title":"DM loss in k haplotype mice reveals isotype-specific chaperone requirements.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12646641","citation_count":31,"is_preprint":false},{"pmid":"8910382","id":"PMC_8910382","title":"Myelin proteolipid protein (PLP), but not DM-20, is an inositol hexakisphosphate-binding protein.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8910382","citation_count":30,"is_preprint":false},{"pmid":"11739502","id":"PMC_11739502","title":"In vivo and in vitro modulation of HLA-DM and HLA-DO is induced by B lymphocyte activation.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11739502","citation_count":29,"is_preprint":false},{"pmid":"9551894","id":"PMC_9551894","title":"MHC class II expression in double mutant mice lacking invariant chain and DM functions.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9551894","citation_count":29,"is_preprint":false},{"pmid":"36425652","id":"PMC_36425652","title":"Wound healing mechanism of antimicrobial peptide cathelicidin-DM.","date":"2022","source":"Frontiers in bioengineering and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36425652","citation_count":28,"is_preprint":false},{"pmid":"11673529","id":"PMC_11673529","title":"Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11673529","citation_count":28,"is_preprint":false},{"pmid":"32242217","id":"PMC_32242217","title":"Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.","date":"2020","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32242217","citation_count":27,"is_preprint":false},{"pmid":"26304544","id":"PMC_26304544","title":"Cooperation meets competition in microRNA-mediated DMPK transcript regulation.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26304544","citation_count":27,"is_preprint":false},{"pmid":"15336691","id":"PMC_15336691","title":"In situ hybridization analysis of Dmpk mRNA in adult mouse tissues.","date":"2004","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/15336691","citation_count":27,"is_preprint":false},{"pmid":"20036899","id":"PMC_20036899","title":"Detailed proteomic analysis on DM: insight into its hypoallergenicity.","date":"2010","source":"Frontiers in bioscience (Elite edition)","url":"https://pubmed.ncbi.nlm.nih.gov/20036899","citation_count":27,"is_preprint":false},{"pmid":"20360842","id":"PMC_20360842","title":"Muscleblind1, but not Dmpk or Six5, contributes to a complex phenotype of muscular and motivational deficits in mouse models of myotonic dystrophy.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20360842","citation_count":27,"is_preprint":false},{"pmid":"10658209","id":"PMC_10658209","title":"Myotonic dystrophy protein kinase (DMPK) induces actin cytoskeletal reorganization and apoptotic-like blebbing in lens cells.","date":"2000","source":"Cell motility and the cytoskeleton","url":"https://pubmed.ncbi.nlm.nih.gov/10658209","citation_count":26,"is_preprint":false},{"pmid":"9297535","id":"PMC_9297535","title":"How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.","date":"1997","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9297535","citation_count":26,"is_preprint":false},{"pmid":"8401505","id":"PMC_8401505","title":"No imprinting involved in the expression of DM-kinase mRNAs in mouse and human tissues.","date":"1993","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8401505","citation_count":26,"is_preprint":false},{"pmid":"31732915","id":"PMC_31732915","title":"Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.","date":"2019","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/31732915","citation_count":25,"is_preprint":false},{"pmid":"2445922","id":"PMC_2445922","title":"Disproportional expression of proteolipid protein and DM-20 in the X-linked, dysmyelinating shaking pup mutant.","date":"1987","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2445922","citation_count":25,"is_preprint":false},{"pmid":"18506881","id":"PMC_18506881","title":"HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition.","date":"2008","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18506881","citation_count":25,"is_preprint":false},{"pmid":"15653313","id":"PMC_15653313","title":"DM and DO shape the repertoire of peptide-MHC-class-II complexes.","date":"2005","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15653313","citation_count":25,"is_preprint":false},{"pmid":"12009208","id":"PMC_12009208","title":"Stabilization of soluble, low-affinity HLA-DM/HLA-DR1 complexes by leucine zippers.","date":"2002","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/12009208","citation_count":25,"is_preprint":false},{"pmid":"12198117","id":"PMC_12198117","title":"Sex-specific gene regulation. The Doublesex DM motif is a bipartite DNA-binding domain.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12198117","citation_count":24,"is_preprint":false},{"pmid":"30467419","id":"PMC_30467419","title":"Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation.","date":"2018","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30467419","citation_count":24,"is_preprint":false},{"pmid":"35102450","id":"PMC_35102450","title":"The Perspective of DMPK on Recombinant Adeno-Associated Virus-Based Gene Therapy: Past Learning, Current Support, and Future Contribution.","date":"2022","source":"The AAPS journal","url":"https://pubmed.ncbi.nlm.nih.gov/35102450","citation_count":23,"is_preprint":false},{"pmid":"31334355","id":"PMC_31334355","title":"DMPK gene DNA methylation levels are associated with muscular and respiratory profiles in DM1.","date":"2019","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31334355","citation_count":23,"is_preprint":false},{"pmid":"26756355","id":"PMC_26756355","title":"Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood.","date":"2016","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/26756355","citation_count":22,"is_preprint":false},{"pmid":"9192285","id":"PMC_9192285","title":"Expression of the dm-20 isoform of the plp gene in olfactory nerve ensheathing cells: evidence from developmental studies.","date":"1997","source":"Journal of neurocytology","url":"https://pubmed.ncbi.nlm.nih.gov/9192285","citation_count":22,"is_preprint":false},{"pmid":"27534821","id":"PMC_27534821","title":"Human leukocyte Antigen-DM polymorphisms in autoimmune diseases.","date":"2016","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/27534821","citation_count":21,"is_preprint":false},{"pmid":"35741732","id":"PMC_35741732","title":"High Resolution Analysis of DMPK Hypermethylation and Repeat Interruptions in Myotonic Dystrophy Type 1.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35741732","citation_count":21,"is_preprint":false},{"pmid":"27543214","id":"PMC_27543214","title":"Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome.","date":"2016","source":"Journal of the American Academy of Dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/27543214","citation_count":21,"is_preprint":false},{"pmid":"32169676","id":"PMC_32169676","title":"Recognition of emotions conveyed by facial expression and body postures in myotonic dystrophy (DM).","date":"2020","source":"Cortex; a journal devoted to the study of the nervous system and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/32169676","citation_count":20,"is_preprint":false},{"pmid":"26610428","id":"PMC_26610428","title":"pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26610428","citation_count":20,"is_preprint":false},{"pmid":"19626675","id":"PMC_19626675","title":"DMPK protein isoforms are differentially expressed in myogenic and neural cell lineages.","date":"2009","source":"Muscle & nerve","url":"https://pubmed.ncbi.nlm.nih.gov/19626675","citation_count":19,"is_preprint":false},{"pmid":"16193250","id":"PMC_16193250","title":"Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1.","date":"2005","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/16193250","citation_count":19,"is_preprint":false},{"pmid":"30700578","id":"PMC_30700578","title":"Expanded CUG repeats in DMPK transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences.","date":"2019","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30700578","citation_count":19,"is_preprint":false},{"pmid":"9952415","id":"PMC_9952415","title":"BEN/SC1/DM-GRASP expression during neuromuscular development: a cell adhesion molecule regulated by innervation.","date":"1999","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9952415","citation_count":19,"is_preprint":false},{"pmid":"12648225","id":"PMC_12648225","title":"Association of TAP and HLA-DM genes with psoriasis in Koreans.","date":"2003","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/12648225","citation_count":19,"is_preprint":false},{"pmid":"31330489","id":"PMC_31330489","title":"DM-RPIs: Predicting ncRNA-protein interactions using stacked ensembling strategy.","date":"2019","source":"Computational biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31330489","citation_count":19,"is_preprint":false},{"pmid":"10625593","id":"PMC_10625593","title":"Quality control of MHC class II associated peptides by HLA-DM/H2-M.","date":"1999","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10625593","citation_count":19,"is_preprint":false},{"pmid":"15684391","id":"PMC_15684391","title":"Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15684391","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45262,"output_tokens":6055,"usd":0.113306,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14984,"output_tokens":5673,"usd":0.108372,"stage2_stop_reason":"end_turn"},"total_usd":0.221678,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"DMPK mRNA transcription from wild-type and mutant (expanded CTG) alleles occurs at equal levels in skeletal muscle and cell lines of heterozygous DM patients, but post-transcriptional processing (splicing/maturation) of the mutant allele transcript is impaired in proportion to repeat size, resulting in reduced processed mRNA from the DM allele.\",\n      \"method\": \"Quantitative allele-specific RT-PCR on patient tissue samples and cell lines\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative allele-specific RT-PCR across multiple patient tissues, single lab with clear mechanistic distinction between transcription and processing steps\",\n      \"pmids\": [\"7590731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Expansion of the CTG repeat in the DMPK 3'UTR results in both reduced levels of primary DMPK transcripts and impaired processing of those transcripts, leading to undetectable levels of processed DMPK mRNA from the mutant allele, as shown in somatic cell hybrids carrying either the normal or mutant allele.\",\n      \"method\": \"Somatic cell hybridization to isolate individual chromosome 19 homologues, followed by RT-PCR amplification of DMPK coding sequences\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isogenic hybrid cell lines separating alleles, RT-PCR; single lab but clean allele-specific experimental design\",\n      \"pmids\": [\"8288237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"DMPK transcripts derived from expanded CTG alleles are retained within the nucleus and absent from the cytoplasm, above a critical threshold of 80–400 CTG repeats; this nuclear retention is specific to DMPK and does not affect mRNA levels of flanking genes SIX5 or DMWD.\",\n      \"method\": \"Subcellular fractionation of RNA combined with allele-specific analysis of DMPK transcripts in DM cell lines; quantitative RNA analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — subcellular fractionation with allele-specific quantification; clear threshold effect demonstrated; findings replicated by multiple independent groups\",\n      \"pmids\": [\"9207102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DMPK gene dosage is a critical determinant of cardiac conduction integrity: DMPK-/- mice develop first-, second-, and third-degree atrioventricular (A-V) block, with specific compromise of the A-V node and His-Purkinje regions; DMPK+/- mice develop first-degree heart block similar to human DM1 patients, establishing haploinsufficiency of DMPK as linked to cardiac conduction disease.\",\n      \"method\": \"In vivo murine electrophysiology in DMPK knockout mice on defined genetic backgrounds\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout/heterozygous mouse model with quantitative electrophysiology; dose-dependent phenotype; peer-reviewed with defined functional readout\",\n      \"pmids\": [\"10021468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A mutant DMPK 3'UTR containing expanded CTG repeats acts in cis to reduce protein expression from the associated reporter gene, and the expanded CUG repeat-containing mRNA acts in trans to inhibit myogenic differentiation of C2C12 myoblasts; deletion analysis mapped both effects to the (CTG)n expansion itself and/or the 3' end of the DMPK 3'UTR.\",\n      \"method\": \"Chimeric reporter constructs with human DMPK 3'UTR in C2C12 mouse myoblasts; deletion analysis; Cre-loxP genetic rescue system\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including reporter assays, deletion analysis, and genetic rescue (Cre-loxP); both cis and trans mechanisms demonstrated in a controlled cell model\",\n      \"pmids\": [\"10484765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"DMPK pre-mRNA undergoes alternative splicing producing six major isoforms with distinct C-terminal sequences and tissue-dependent expression: four ~74 kDa full-length isoforms (heart-, skeletal muscle-, brain-specific) and two ~68 kDa C-terminally truncated isoforms (smooth muscle-specific), arising from combinations of cryptic splice sites in exons 8 and 14 and regulated excision of exons 13/14.\",\n      \"method\": \"Transgenic DMPK-overexpressor mouse model; transfection of all six full-length mouse cDNAs into cells; characterization of mRNA and protein isoform distributions\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic mouse model plus cell transfection of all isoforms; multiple tissues analyzed; isoform-specific protein expression confirmed\",\n      \"pmids\": [\"10699184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Four RNA splicing factors—hnRNP C, U2AF, PTB (polypyrimidine tract binding protein), and PSF (PTB-associated splicing factor)—bind to two short regions 3' of the CUG repeat in DMPK 3'UTR; the CUG repeat acts as an essential cis element for a splicing event that produces a novel 3' DMPK exon generating an mRNA isoform that lacks the repeats and is not retained in the nucleus in DM cells.\",\n      \"method\": \"Identification of splicing factors binding to DMPK 3'UTR regions; characterization of novel splice isoform; analysis of nuclear retention of isoforms in DM cells\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-binding protein identification combined with novel isoform characterization and nuclear retention analysis; single lab\",\n      \"pmids\": [\"10911990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"DMPK overexpression in cultured lens epithelial cells leads to apoptotic-like blebbing of the plasma membrane and reorganization of the actin cytoskeleton; enzymatically active DMPK (but not kinase-inactive mutant DMPK) is required for both effects, and active RhoA produces similar effects, suggesting DMPK and RhoA function in the same regulatory network.\",\n      \"method\": \"Overexpression of wild-type and kinase-inactive DMPK mutants in lens epithelial cells; comparison with constitutively active and GDP-state RhoA mutants; assessment of actin cytoskeletal morphology and membrane blebbing\",\n      \"journal\": \"Cell motility and the cytoskeleton\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — active-site mutagenesis combined with overexpression and comparison to RhoA pathway; single lab; cellular phenotype with defined kinase-activity requirement\",\n      \"pmids\": [\"10658209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GFP-tagged MBNL protein co-localizes with expanded DMPK repeat transcript nuclear foci in DM1 cell lines, forming discrete nuclear foci itself only in DM1 (not normal) cells, providing evidence that MBNL is sequestered by expanded CUG repeat DMPK transcripts.\",\n      \"method\": \"Indirect immunofluorescence and overexpression of GFP-tagged MBNL, CUG-BP, and hnRNP C in DM1 cell lines; co-localization with expanded repeat RNA foci\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-localization by fluorescence imaging; single lab; replicated by multiple groups in the field supporting MBNL sequestration model\",\n      \"pmids\": [\"11433021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"DMPK protein level is reduced by approximately 50% in DM1 fetal muscle cells relative to normal cells; mutant DMPK transcripts are retained in discrete nuclear foci, and DMPK mRNA levels increase sharply during myoblast differentiation.\",\n      \"method\": \"Immunoblotting with anti-DMPK antibody; fluorescence in situ hybridization for RNA foci in primary human DM1 myoblasts\",\n      \"journal\": \"Neuromuscular disorders : NMD\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — immunoblot quantification and FISH; single lab; consistent with multiple reports of DMPK haploinsufficiency\",\n      \"pmids\": [\"11595515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Mutant DMPK 3'UTR transcripts containing (CUG)200 disrupt C2C12 myoblast differentiation by reducing MyoD protein levels below the threshold required to activate the differentiation program; restoring MyoD levels rescues the differentiation defect.\",\n      \"method\": \"C2C12 cell culture model with mutant DMPK 3'UTR expression constructs; MyoD protein measurement by immunoblot; E-box reporter assays; MyoD rescue experiment\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (protein quantification, reporter assays, rescue experiment); defined molecular mechanism linking mutant DMPK RNA to MyoD reduction and differentiation block\",\n      \"pmids\": [\"12427866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Transgenic overexpression of human DMPK in mice results in hypertrophic cardiomyopathy (myocardial hypertrophy, myocyte disarray, interstitial fibrosis, calcium overload), myotonic myopathy with sarcolemmal chloride channel deficit, and reduced blood pressure, demonstrating that DMPK overexpression in cardiac, skeletal, and smooth muscle cells causes DM1-like pathological changes.\",\n      \"method\": \"Aged transgenic mice carrying ~25 extra copies of complete hDMPK gene; cardiac and skeletal muscle histology, electrophysiology (myotonic discharges), blood pressure measurement, exercise testing\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic overexpressor model with multiple orthogonal phenotypic readouts in multiple muscle types; controlled comparison with age-matched wild-type mice\",\n      \"pmids\": [\"15317754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DMPK splice isoform A localizes predominantly to the outer mitochondrial membrane, while isoform C localizes to the endoplasmic reticulum (in mouse); unique sequence arrangements in C-terminal tail anchors control isoform-specific intracellular membrane targeting; expression of isoforms A/C caused clustering of ER or mitochondria respectively; mutagenesis of basic residues flanking putative transmembrane domains disrupted proper anchoring, identifying DMPK as the first kinase class of tail-anchored proteins.\",\n      \"method\": \"Expression of individual DMPK isoforms in C2C12 and DMPK-/- myoblast cells; subcellular fractionation; alkaline resistance assay; mutagenesis of tail-anchor basic residues; live-cell imaging of organelle distribution\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — mutagenesis of tail-anchor residues combined with subcellular fractionation, alkaline resistance, and organelle imaging in multiple cell types; multiple orthogonal methods establishing mechanism\",\n      \"pmids\": [\"15684391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DMPK is a positive modulator of insulin action specifically in muscle: DMPK-deficient mice exhibit impaired insulin signaling in muscle but not in adipocytes or liver (tissues lacking DMPK expression), abnormal glucose tolerance, reduced glucose uptake, and impaired insulin-dependent GLUT4 trafficking in muscle; DMPK mutant analysis showed DMPK is required for correct intracellular trafficking of insulin and IGF-1 receptors.\",\n      \"method\": \"DMPK knockout mice; glucose tolerance tests; glucose uptake assays; GLUT4 trafficking assays; DMPK mutant constructs in cultured muscle cells; tissue-specific phenotype analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse model with multiple metabolic phenotype readouts; tissue-specific effect correlated with tissue-specific DMPK expression; DMPK mutant analysis in cells; multiple orthogonal methods\",\n      \"pmids\": [\"17987120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The long DMPK isoforms (DMPK-A/B/C/D) are associated with the outer mitochondrial membrane; DMPK-A kinase activity protects cells from oxidative stress and prevents mitochondrial permeability transition pore (PTP) opening; DMPK forms a multimeric complex with hexokinase II (HK II) and the active form of the tyrosine kinase Src (binding its SH3 domain); DMPK is tyrosine-phosphorylated by Src; both the complex and tyrosine phosphorylation of DMPK increase under oxidative stress; DMPK increases mitochondrial localization of HK II; Src inhibition selectively enhances death in DMPK-expressing cells after HK II detachment.\",\n      \"method\": \"Co-immunoprecipitation; subcellular fractionation; SH3 domain binding assay; kinase activity assays; DMPK knockdown; oxidative stress treatments; permeability transition pore assay; in vitro myogenesis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods: co-IP, biochemical fractionation, kinase assay, SH3 binding, PTP assay, functional knockdown; complex membership and phosphorylation directly demonstrated\",\n      \"pmids\": [\"24136222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The DEAD-box helicase DDX6 interacts with CUG triplet-repeat DMPK mRNA in primary DM1 patient fibroblasts and with CUG-RNA in vitro; DDX6 overexpression reduces nuclear DMPK-mRNA foci and relieves DM1 mis-splicing without changing total CUG-expanded mRNA levels (causes re-localization to cytoplasm); DDX6 knockdown increases nuclear DMPK-mRNA foci and MBNL1 nuclear sequestration; DDX6 unwinds CUG-repeat duplexes in vitro in an ATP-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation in primary DM1 fibroblasts; in vitro RNA unwinding assay; DDX6 overexpression and knockdown; fluorescence microscopy for RNA foci; splicing assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro helicase assay plus reciprocal cellular experiments (overexpression and knockdown) with multiple readouts (foci, splicing, MBNL1 localization); mechanistic chain from DDX6-CUG binding to foci resolution established\",\n      \"pmids\": [\"24792155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Dmpk gene deletion or >90% ASO-mediated knockdown of DMPK in cardiac and skeletal muscle of mice does not compromise cardiac function (ECG intervals, ejection fraction) or muscle strength, even under cardiac stress (pressure overload) or muscle stress (myotonia), challenging earlier reports of cardiac defects in DMPK knockout mice.\",\n      \"method\": \"Dmpk knockout mice on two genetic backgrounds; heterozygous knockout mice treated with DMPK-targeting ASOs; ECG measurement, cardiac ejection fraction, muscle strength testing, pressure overload and myotonia stress models\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout and ASO knockdown on two genetic backgrounds with multiple functional readouts; reports negative/null result for cardiac/muscle function but contradicts an earlier positive report (PMID 10021468); confidence reduced due to contradiction\",\n      \"pmids\": [\"27522499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Long membrane-anchored DMPK isoforms are the dominant form in heart, diaphragm, and skeletal muscle, while short cytosolic isoforms are highly expressed in bladder and stomach; both isoform types are present in diverse brain regions; DMPK protein is detectable in myoblasts, myotubes, cortical astrocytes, and related cell lines but not in hippocampal neurons.\",\n      \"method\": \"Immunoblotting and RT-PCR for DMPK isoforms in mouse tissue panels and cultured cell types\",\n      \"journal\": \"Muscle & nerve\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — protein and mRNA isoform profiling across multiple tissues and cell types; single lab; establishes tissue-specific isoform expression pattern\",\n      \"pmids\": [\"19626675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Expanded CUG repeats in DMPK 3'UTR RNA form length-dependent hairpin structures with conformational plasticity (including branched structures for long repeats), embedded in an otherwise rigid flanking architecture; SHAPE, DMS, CMCT, and RNase T1 probing showed the flanking sequences maintain fixed structure regardless of repeat length; LNA antisense oligonucleotides designed using this structural model confirmed DMPK knockdown in cells.\",\n      \"method\": \"SHAPE, DMS, CMCT, and RNase T1 RNA structure probing in vitro; LNA antisense oligonucleotide disruption of base-pairing; functional DMPK knockdown validation in cells\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal in vitro structure probing methods (SHAPE, DMS, CMCT, RNase T1) with functional validation via AON knockdown; rigorous multi-method structural characterization\",\n      \"pmids\": [\"30700578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CTG repeat expansion in the DMPK gene leads to a loss of a nuclease-hypersensitive chromatin site near the repeat, indicating altered chromatin structure; this chromatin change is associated with markedly reduced DMPK mRNA from expanded alleles, partially reduced SIX5 expression (in congenital DM), but no reduction of DMWD mRNA; most DMPK transcripts from expanded alleles lack exons 13 and 14, suggesting the expansion affects 3' splicing.\",\n      \"method\": \"PCR-based chromatin sensitivity assay in somatic cell hybrids carrying normal or expanded alleles; semiquantitative multiplex RT-PCR; nested RT-PCR for splice isoform analysis\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — allele-specific analysis in somatic cell hybrids with both chromatin and transcriptional readouts; single lab; multiple methods\",\n      \"pmids\": [\"11592825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"DMPK protein (DMK) in human and rodent tissues is detected as ~74 kDa and ~82 kDa species in cardiac and skeletal muscle; by immunofluorescence, DMK localizes post-synaptically at neuromuscular junctions of skeletal muscle, at intercalated discs of cardiac tissue, and at the apical membrane of ependyma and choroid plexus; synaptic localization was also noted in cerebellum, hippocampus, midbrain and medulla.\",\n      \"method\": \"Immunoblotting with polyclonal antibody against C-terminal DMPK fusion protein; immunofluorescence microscopy on muscle and brain tissue sections\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — immunofluorescence localization in multiple tissues; specific antibody validated against recombinant DMPK; single lab\",\n      \"pmids\": [\"7655460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Using a panel of 16 monoclonal antibodies, DMPK was detected as a single ~80 kDa protein exclusively in skeletal muscle, cardiac muscle, and to a lesser extent smooth muscle; a shared epitope at the catalytic site of DMPK was identified using a phage-displayed random peptide library; DMPK shares epitopes with MRCK alpha and beta (related kinases).\",\n      \"method\": \"Monoclonal antibody panel immunoblotting across human tissue panel; phage-displayed random peptide library for epitope mapping; cDNA library screening\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic monoclonal antibody panel with 16 antibodies; epitope mapping by phage display; single lab but comprehensive tissue survey\",\n      \"pmids\": [\"10958655\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DMPK encodes a serine/threonine protein kinase (homologous to ROCK/MRCK) expressed predominantly in muscle and heart, existing as multiple alternatively spliced isoforms that differentially localize to the outer mitochondrial membrane or ER via unique C-terminal tail anchors; its kinase activity regulates actin cytoskeletal organization, protects mitochondria from oxidative stress by assembling a HK II–Src complex, and modulates insulin receptor trafficking and muscle insulin action, while haploinsufficiency caused by CTG repeat expansion—which impairs post-transcriptional processing and nuclear export of DMPK mRNA—contributes to cardiac conduction defects and insulin resistance, and the toxic expanded CUG repeat-containing mRNA acts in trans to sequester MBNL proteins, reduce MyoD levels, and disrupt myogenic differentiation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DMPK encodes a muscle- and heart-enriched serine/threonine protein kinase whose normal cellular role and disease-causing CTG repeat expansion represent two functionally distinct axes [#11, #2]. As a kinase, DMPK regulates the actin cytoskeleton, with enzymatically active (but not kinase-dead) DMPK driving actin reorganization and membrane blebbing in a manner parallel to active RhoA [#7]. Alternative splicing generates multiple isoforms with distinct C-terminal tail anchors that target individual isoforms to either the outer mitochondrial membrane or the endoplasmic reticulum, defining DMPK as a tail-anchored kinase [#5, #12]. At the mitochondrion, the kinase activity of long DMPK isoforms protects cells from oxidative stress and prevents permeability transition pore opening by assembling a complex with hexokinase II and active Src—which tyrosine-phosphorylates DMPK and stabilizes mitochondrial HK II localization under stress [#14]. DMPK also acts as a positive, muscle-specific modulator of insulin action, being required for correct trafficking of insulin/IGF-1 receptors and insulin-dependent GLUT4 trafficking [#13]. The DM1 disease mechanism operates through the expanded (CTG)n repeat in the DMPK 3'UTR: above a repeat-length threshold the mutant transcript is poorly processed and retained in the nucleus as discrete RNA foci, halving DMPK protein levels (haploinsufficiency), while flanking-gene transcripts are spared [#1, #2, #9]. The expanded CUG-repeat RNA additionally exerts a trans-dominant toxic gain of function, forming length-dependent hairpin structures [#18] that sequester MBNL protein into nuclear foci [#8] and reduce MyoD below the level needed to drive myogenic differentiation [#10, #4]. The RNA helicase DDX6 binds and unwinds CUG-repeat duplexes, relocalizing the toxic transcript to the cytoplasm and relieving mis-splicing [#15]. Whether DMPK gene dosage is causally required for cardiac conduction is unresolved within the corpus: an early knockout study reported dose-dependent atrioventricular block [#3], whereas a later knockout/ASO study found no cardiac or muscle functional deficit [#16].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established that CTG expansion does not simply abolish transcription but instead impairs transcript processing, reframing DM1 as a post-transcriptional rather than purely transcriptional defect.\",\n      \"evidence\": \"Somatic cell hybrids separating normal and mutant chromosome 19 alleles followed by RT-PCR\",\n      \"pmids\": [\"8288237\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not localize where in processing the block occurs\", \"Single-lab allele-specific design\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Distinguished equal transcription from repeat-length-dependent impaired processing of the mutant allele, quantifying the haploinsufficiency mechanism.\",\n      \"evidence\": \"Quantitative allele-specific RT-PCR across patient tissues and cell lines\",\n      \"pmids\": [\"7590731\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of processing block not defined\", \"No protein-level quantification\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Defined DMPK protein size and subcellular localization, placing the kinase at neuromuscular junctions, intercalated discs, and synaptic sites.\",\n      \"evidence\": \"Immunoblotting and immunofluorescence with C-terminal DMPK antibody on muscle and brain tissue\",\n      \"pmids\": [\"7655460\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Antibody could not distinguish isoforms functionally\", \"Localization correlation with function not tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed the mutant transcript is retained in the nucleus above a defined repeat threshold and that retention is gene-specific, establishing the physical basis for both haploinsufficiency and RNA toxicity.\",\n      \"evidence\": \"Subcellular RNA fractionation with allele-specific quantification in DM cell lines\",\n      \"pmids\": [\"9207102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify proteins mediating retention\", \"Did not establish downstream toxicity\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrated dose-dependent cardiac conduction disease in DMPK knockout and heterozygous mice, arguing that DMPK haploinsufficiency contributes to DM1 heart block.\",\n      \"evidence\": \"In vivo electrophysiology in DMPK-/- and DMPK+/- mice\",\n      \"pmids\": [\"10021468\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular substrate of conduction defect not identified\", \"Later contradicted by negative knockout/ASO study\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Separated cis (reduced reporter expression) from trans (myogenic differentiation block) effects of the expanded repeat, establishing the dual-mechanism framework for DM1.\",\n      \"evidence\": \"Chimeric reporter constructs and deletion analysis with Cre-loxP rescue in C2C12 myoblasts\",\n      \"pmids\": [\"10484765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify trans-acting factors mediating toxicity\", \"Effects mapped to repeat region but not single nucleotide resolution\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Catalogued six tissue-specific spliced isoforms with distinct C-termini, providing the molecular basis for differential isoform targeting and function.\",\n      \"evidence\": \"Transgenic DMPK-overexpressor mice and transfection of all six cDNAs\",\n      \"pmids\": [\"10699184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional differences between isoforms not yet assigned\", \"Localization not yet mapped\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified splicing factors binding 3' of the CUG repeat and a repeat-dependent splice event producing a non-retained, repeat-lacking isoform, hinting at an escape route from nuclear retention.\",\n      \"evidence\": \"RNA-binding protein identification and novel isoform characterization in DM cells\",\n      \"pmids\": [\"10911990\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of escape isoform not quantified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Linked DMPK kinase activity to actin cytoskeletal reorganization and membrane blebbing, placing DMPK in a RhoA-related signaling network.\",\n      \"evidence\": \"Wild-type versus kinase-inactive DMPK overexpression compared with RhoA mutants in lens epithelial cells\",\n      \"pmids\": [\"10658209\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct substrates not identified\", \"Non-muscle cell model\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Confirmed muscle-restricted DMPK expression and a shared catalytic-site epitope with the related kinases MRCK alpha/beta.\",\n      \"evidence\": \"16-monoclonal-antibody tissue panel and phage-display epitope mapping\",\n      \"pmids\": [\"10958655\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of MRCK relatedness not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Provided direct imaging evidence that MBNL is sequestered onto expanded-repeat DMPK RNA foci, advancing the trans RNA-toxicity model.\",\n      \"evidence\": \"GFP-tagged MBNL co-localization with repeat RNA foci in DM1 cells\",\n      \"pmids\": [\"11433021\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-localization not quantitatively binding affinity\", \"Functional splicing consequences of sequestration not measured here\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Quantified ~50% DMPK protein reduction in DM1 muscle cells alongside nuclear RNA foci, directly linking nuclear retention to haploinsufficiency.\",\n      \"evidence\": \"Immunoblotting and FISH in primary human DM1 myoblasts\",\n      \"pmids\": [\"11595515\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Causal contribution of 50% loss to phenotype not isolated\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Connected CTG expansion to altered local chromatin structure and exon 13/14-deficient transcripts, adding a chromatin-level layer to expression silencing.\",\n      \"evidence\": \"Chromatin sensitivity assay and RT-PCR in somatic cell hybrids\",\n      \"pmids\": [\"11592825\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Chromatin change mechanism not defined\", \"Relative contribution versus RNA retention unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Pinpointed MyoD depletion below an activation threshold as the molecular cause of repeat-RNA-induced differentiation failure, with MyoD restoration rescuing the defect.\",\n      \"evidence\": \"(CUG)200 3'UTR constructs, MyoD immunoblot, E-box reporters, and rescue in C2C12\",\n      \"pmids\": [\"12427866\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking RNA foci to MyoD reduction not fully defined\", \"Cell-line model only\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated that DMPK overexpression alone reproduces DM1-like cardiac, skeletal, and smooth muscle pathology, implicating dosage in disease beyond loss of function.\",\n      \"evidence\": \"Transgenic mice with ~25 extra hDMPK copies; histology, electrophysiology, blood pressure\",\n      \"pmids\": [\"15317754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Overexpression level non-physiological\", \"Does not separate kinase activity from gene dosage\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established isoform-specific tail-anchor targeting to mitochondria versus ER, identifying DMPK as the first tail-anchored protein kinase and giving a structural basis for compartmentalized function.\",\n      \"evidence\": \"Isoform expression, subcellular fractionation, alkaline resistance, tail-anchor mutagenesis, and imaging in myoblasts\",\n      \"pmids\": [\"15684391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional output at each organelle not yet defined\", \"Targeting machinery not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined DMPK as a muscle-specific positive regulator of insulin signaling required for insulin/IGF-1 receptor and GLUT4 trafficking, linking DMPK loss to the insulin resistance of DM1.\",\n      \"evidence\": \"Knockout mice with glucose tolerance, uptake, and GLUT4 trafficking assays plus DMPK mutant cells\",\n      \"pmids\": [\"17987120\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct kinase substrates in the trafficking pathway not identified\", \"Molecular link between DMPK and receptor trafficking unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Refined the tissue map of membrane-anchored versus cytosolic DMPK isoforms across muscle, visceral, and brain tissues, framing where each functional pool acts.\",\n      \"evidence\": \"Immunoblot and RT-PCR isoform profiling across mouse tissues and cell types\",\n      \"pmids\": [\"19626675\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of isoform distribution not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Resolved a mitochondrial protective mechanism in which long DMPK isoforms assemble an HK II–Src complex, are tyrosine-phosphorylated by Src, and prevent permeability transition pore opening under oxidative stress.\",\n      \"evidence\": \"Co-IP, fractionation, SH3 binding, kinase and PTP assays, and knockdown under oxidative stress\",\n      \"pmids\": [\"24136222\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DMPK phosphorylation substrates at the mitochondrion not identified\", \"In vivo relevance to DM1 not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified DDX6 as a CUG-repeat helicase that unwinds the toxic duplex, relocalizes the transcript to the cytoplasm, and relieves MBNL1 sequestration and mis-splicing, offering a route to counter RNA toxicity.\",\n      \"evidence\": \"Co-IP in DM1 fibroblasts, in vitro ATP-dependent unwinding, and reciprocal overexpression/knockdown\",\n      \"pmids\": [\"24792155\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous regulation of DDX6 in DM1 tissue not addressed\", \"Therapeutic feasibility untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Provided a structural model of length-dependent CUG hairpins within a rigid flanking architecture and validated structure-guided antisense knockdown.\",\n      \"evidence\": \"SHAPE/DMS/CMCT/RNase T1 probing in vitro plus LNA antisense knockdown in cells\",\n      \"pmids\": [\"30700578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of repeat in cellular context with bound proteins not resolved\", \"Branched-structure functional consequence not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Whether DMPK gene dosage is causally required for cardiac conduction and muscle function in vivo remains unresolved, given directly contradictory knockout results.\",\n      \"evidence\": \"Contradiction between dose-dependent AV block (10021468) and null cardiac/muscle phenotype under stress (27522499)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genetic background and modifier effects not reconciled\", \"Direct kinase substrates underlying any cardiac role not identified\", \"Relative weighting of haploinsufficiency versus RNA toxicity in cardiac disease unsettled\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [7, 14]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [7, 14, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [12, 14, 17]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 4, 10]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [6, 8, 15]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 13]}\n    ],\n    \"complexes\": [\n      \"DMPK–hexokinase II–Src mitochondrial complex\"\n    ],\n    \"partners\": [\n      \"HK2\",\n      \"SRC\",\n      \"MBNL1\",\n      \"DDX6\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}